Meeting
2022 ASCO Genitourinary Cancers Symposium
Expression of Nectin-4 and PD-L1 in bladder cancer with variant histology.
Authors
Katherine Case
Department of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, GA
Katherine Case , Dylan J. Martini , Melad Dababneh , Bassel Nazha , Jacqueline T Brown , Shreyas S. Joshi , Vikram M. Narayan , Kenneth Ogan , Viraj A. Master , Bradley Curtis Carthon , Omer Kucuk , Lara Harik , Mehmet Asim Bilen
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B: Urothelial Carcinoma
Track
Urothelial Carcinoma
Sub Track
Translational Research, Tumor Biology, Biomarkers, and Pathology
Citation
J Clin Oncol 40, 2022 (suppl 6; abstr 529)
DOI
10.1200/JCO.2022.40.6_suppl.529
Abstract #
529
Poster Bd #
H5
Abstract Disclosures
Similar Posters
Poster
2019 Genitourinary Cancers Symposium
Programmed death-ligand 1 (PD-L1) expression in pheochromocytoma.
First Author: Yasuhiro Hashimoto
Poster
2018 Genitourinary Cancers Symposium
Discordance rate of PD-L1 expression between primary and metastatic lesions in urothelial carcinoma (UC).
First Author: Earle Frederick Burgess
Poster
2018 Genitourinary Cancers Symposium
Post-chemotherapy PD-L1 expression correlates with clinical outcomes in Japanese bladder cancer patients treated with total cystectomy.
First Author: Yasuhiro Hashimoto
Poster
2016 Genitourinary Cancers Symposium
The expression and clinical significance of PD-L1 in patients with upper tract urothelial carcinoma.
First Author: Xinan Sheng